You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

lymphoid cells

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Type 2 Innate Lymphoid Cells in Severe Pediatric Asthma

Withdrawn
  • Severe Asthma
  • Biopsy
  • +2 more
  • Paris, France
    Hôpital Necker Enfants malades
Nov 7, 2022

Sexual Bias in Type 2 Innate Lymphoid Cells in Asthmatic

Recruiting
  • Asthma
  • Blood sample collection (one tube)
  • Blood sample collection (five tubes)
  • Toulouse, France
    Larrey hospital
May 17, 2022

Innate Lymphoid Cells in Peripheral Blood in ALS

Terminated
  • Amyotrophic Lateral Sclerosis
  • Blood draw
  • Ann Arbor, Michigan
    University of Michigan
Dec 22, 2021

B-Lymphoid Malignancies, Acute Lymphocytic Leukemia, Chronic Lymphocytic Leukemia Trial in Houston (Fludarabine,

Active, not recruiting
  • B-Lymphoid Malignancies
  • +3 more
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Aug 1, 2022

Non Hodgkin Lymphoma, Acute Lymphoblastic Leukemia, Chronic Lymphocytic Leukemia Trial in Cleveland (Fully human anti CD19 CAR-T

Recruiting
  • Non Hodgkin Lymphoma
  • +2 more
  • Fully human anti CD19 CAR-T Cell Dose
  • +2 more
  • Cleveland, Ohio
    University Hospitals Cleveland Medical Center, Case Comprehensiv
Oct 4, 2022

B-Cell Lymphoid Malignancies, Hematologic Malignancy, Non-Hodgkin Lymphoma Trial in Miami (Hematopoietic Stem Cells from

Recruiting
  • B-Cell Lymphoid Malignancies
  • +2 more
  • Hematopoietic Stem Cells from HLA-compatible Related
  • Hematopoietic Stem Cells from HLA Unrelated
  • Miami, Florida
    Miami Cancer Institute at Baptist Health of South Florida
May 5, 2022

Acute Lymphoblastic Leukemia, in Relapse, Acute Lymphoblastic Leukemia Refractory, B-cell Lymphoma Recurrent Trial in São Paulo

Not yet recruiting
  • Acute Lymphoblastic Leukemia, in Relapse
  • +5 more
  • São Paulo, Brazil
    Hospital Israelita Albert Einstein
Jan 20, 2023

Determination of Blood Tumor Cells

Completed
  • Leukemia, Lymphocytic, Chronic, B-Cell
  • Abnormalities Cell Epithelial
    • Zurich, Switzerland
      University Hospital Zurich
    Jan 9, 2023

    B-cell Acute Lymphoblastic Leukemia Trial (CD19-CAR_Lenti_ALLO)

    Not yet recruiting
    • B-cell Acute Lymphoblastic Leukemia
    • (no location specified)
    Oct 10, 2023

    T-Cell Lymphocytic Leukemia, T-Cell Chronic Lymphocytic Leukemia, T Cell Non-Hodgkin Lymphoma Trial in Wuhan (Fludarabine +

    Recruiting
    • T-Cell Lymphocytic Leukemia
    • +2 more
    • Fludarabine + Cyclophosphamide + CAR7-T Cells
    • Wuhan, Hubei, China
      Union Hospital, Huazhong University of Science and Technology
    Mar 1, 2022

    Recurrent Acute Lymphoblastic Leukemia, Recurrent B Acute Lymphoblastic Leukemia, Recurrent B-Cell Prolymphocytic Leukemia Trial

    Recruiting
    • Recurrent Acute Lymphoblastic Leukemia
    • +15 more
    • Anti-CD19/CD20/CD22 CAR T-Cells
    • +2 more
    • Columbus, Ohio
      Ohio State University Comprehensive Cancer Center
    Nov 4, 2022

    T-Cell Acute Lymphoblastic Leukemia/Lymphoblastic Lymphoma Trial (CD7-CART01)

    Not yet recruiting
    • T-Cell Acute Lymphoblastic Leukemia/Lymphoblastic Lymphoma
    • CD7-CART01
    • (no location specified)
    Sep 26, 2023

    Leukemia, Acute Lymphoblastic Leukemia Trial in New York (gene-modified T cells targeted)

    Active, not recruiting
    • Leukemia
    • Acute Lymphoblastic Leukemia
    • gene-modified T cells targeted
    • New York, New York
      Memorial Sloan Kettering Cancer Center
    Feb 1, 2023

    B-cell Acute Lymphoblastic Leukemia, Non-Hodgkin's Lymphoma, Relapsed, Non-Hodgkin's Lymphoma Refractory Trial in Taipei (RPM

    Terminated
    • B-cell Acute Lymphoblastic Leukemia
    • +7 more
    • RPM CD19-mbIL15-CAR-T cells
    • Taipei, Taiwan
      National Taiwan University Hospital
    May 11, 2022

    Chronic Lymphocytic Leukemia, B-Cell Chronic Lymphocytic Leukemia, Lymphoma, B-Cell Trial run by the National Cancer Institute

    Not yet recruiting
    • Chronic Lymphocytic Leukemia
    • +2 more
    • Anti-CD19 and anti-CD20 bicistronic CAR T- cells
    • +2 more
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Apr 10, 2023

    Immune System Trial in Reus (Almond intervention, Control)

    Recruiting
    • Immune System
    • Almond intervention
    • Control
    • Reus, Tarragona, Spain
      IISPV
    Oct 5, 2021

    Relapsed/Refractory T-cell Acute Lymphoid Leukaemia Trial in London (Cryopreserved BE CAR7 T cells (BE752TBCCLCAR7PBL))

    Recruiting
    • Relapsed/Refractory T-cell Acute Lymphoid Leukaemia
    • Cryopreserved BE CAR7 T cells (BE752TBCCLCAR7PBL)
    • London, United Kingdom
      Ilyas Ali
    May 25, 2022

    Acute Lymphocytic Leukemia Trial in Tianjin (CD19-targeted Chimeric Antigen Receptor (CAR) T Cells)

    Recruiting
    • Acute Lymphocytic Leukemia
    • CD19-targeted Chimeric Antigen Receptor (CAR) T Cells
    • Tianjin, Tianjin, China
      Hematology Hospital, Chinese Academy of Medical Sciences
    Feb 5, 2023

    Human Immunodeficiency Virus (HIV) Trial in Rochester (Ixazomib 1 MG, Ixazomib 2 MG, Ixazomib 3 MG)

    Completed
    Has Results
    • Human Immunodeficiency Virus (HIV)
    • Ixazomib 1 MG
    • +3 more
    • Rochester, Minnesota
      Mayo Clinic
    Dec 8, 2021

    Acute Lymphoid Leukemia, Acute Lymphoblastic Leukemia Trial in Aurora (CD19 Directed CAR T Cell)

    Not yet recruiting
    • Acute Lymphoid Leukemia
    • Acute Lymphoblastic Leukemia
    • CD19 Directed CAR T Cell
    • Aurora, Colorado
      University of Colorado Hospital
    Sep 12, 2022

    Acute Myeloid Leukemia (AML), B-cell Non-Hodgkin's Lymphoma (B-NHL), Multiple Myeloma (MM) Trial in Shanghai (Autologous CAR-T

    Recruiting
    • Acute Myeloid Leukemia (AML)
    • +4 more
    • Autologous CAR-T cells
    • +2 more
    • Shanghai, Shanghai, China
      Shanghai Pudong Hospital, Fudan University Affiliated Pudong Med
    Aug 22, 2022

    Acute Lymphoblastic Leukemia Trial in Sanhe (CAR-NK-CD19 Cells)

    Completed
    • Acute Lymphoblastic Leukemia
    • CAR-NK-CD19 Cells
    • Sanhe, Hebei, China
      Hebei Yanda Ludaopei Hospital
    Nov 24, 2022

    Lymphoid Leukemia Trial in Palo Alto (Allogeneic donor-derived T-cells transduced with bivalent lentiviral vector

    Not yet recruiting
    • Lymphoid Leukemia
    • Allogeneic donor-derived T-cells transduced with bivalent lentiviral vector (CD19/CD22-BBz) chimeric antigen receptor (CAR)
    • Treg CD34+ HSPC (Orca-T)
    • Palo Alto, California
      Stanford Cancer Center
    Aug 17, 2022

    B-cell Acute Lymphoblastic Leukemia, B-ALL Trial in Kunming (UCAR-T Cells)

    Recruiting
    • B-cell Acute Lymphoblastic Leukemia
    • B-ALL
    • UCAR-T Cells
    • Kunming, Yunnan, China
      920th Hospital of Joint Logistics Support Force of People's Libe
    Dec 7, 2022

    Acute Lymphoid Leukemia, B-Cell Leukemia, Leukemia, Lymphocytic, B Cell Trial run by the National Cancer Institute (NCI)

    Not yet recruiting
    • Acute Lymphoid Leukemia
    • +4 more
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Aug 17, 2022